Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected

OBJECTIVES: The emergence of new variants of concern (VOCs) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) around the world significantly complicated the exit from Coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to evaluate the serum neutralizing activity of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Infect
Главные авторы: Gidari, Anna, Sabbatini, Samuele, Bastianelli, Sabrina, Pierucci, Sara, Busti, Chiara, Monari, Claudia, Luciani Pasqua, Barbara, Dragoni, Filippo, Schiaroli, Elisabetta, Zazzi, Maurizio, Francisci, Daniela
Формат: Artigo
Язык:Inglês
Опубликовано: The British Infection Association. Published by Elsevier Ltd. 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310664/
https://ncbi.nlm.nih.gov/pubmed/34320390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jinf.2021.07.019
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы